Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02851875 · ClinicalTrials.gov registry record
Duke Scleroderma Clinic Patient Registry
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 42
- Enrollment target
NCT02851875 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 42 participants.
The verdict
NCT02851875 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The purpose of the Duke Scleroderma Registry (DSScR) is to obtain information about scleroderma. This information could be used in future research to increase the understanding of disease mechanisms, treatments, and outcomes. This research may also help develop new therapies, novel measures of disease assessment or identify previously unknown manifestations of the diseases. A prospectively followed cohort is an integral component of future translational and clinical research programs. A registry for scleroderma would allow for information to be gleaned about patients in "real-world situations" in an effort to improve the reality, generalizability and applicability of information gathered.
Interventions
- OTHER Registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-05-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02851875
The ClinicalTrials.gov registry entry for NCT02851875 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Registry is the first listed.
NCT02851875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02851875 about?
NCT02851875 is a clinical study titled "Duke Scleroderma Clinic Patient Registry". The purpose of the Duke Scleroderma Registry (DSScR) is to obtain information about scleroderma. This information could be used in future research to increase the understanding of disease mechanisms, treatments, and outcomes. This research may also help develop new therapies, novel measures of disea...
What is the current status of trial NCT02851875?
This trial is currently terminated. The enrollment target is 42 participants. The study started on 2016-04. Estimated completion is 2018-05-07.
What interventions are being tested in trial NCT02851875?
The interventions under investigation include: Registry (OTHER).
Who is sponsoring clinical trial NCT02851875?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.